137 related articles for article (PubMed ID: 23956362)
1. eComment. Potential therapeutic agents in vasoplegic syndrome after cardiac surgery.
Yavuz S; Toktas F; Surer S; Eris C
Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):530-1. PubMed ID: 23956362
[No Abstract] [Full Text] [Related]
2. Pre-existing endothelial cell activation predicts vasoplegia after mitral valve surgery.
Kortekaas KA; Lindeman JH; Reinders ME; Palmen M; Klautz RJ; de Groot PG; Roest M
Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):523-30. PubMed ID: 23736659
[TBL] [Abstract][Full Text] [Related]
3. Vasoplegia After Restrictive Mitral Annuloplasty for Functional Mitral Regurgitation in Patients With Heart Failure.
van Vessem ME; Petrus AHJ; Palmen M; Braun J; Schalij MJ; Klautz RJM; Beeres SLMA
J Cardiothorac Vasc Anesth; 2019 Dec; 33(12):3273-3280. PubMed ID: 31350152
[TBL] [Abstract][Full Text] [Related]
4. Methylene Blue for Vasoplegic Syndrome.
Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C
Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290
[TBL] [Abstract][Full Text] [Related]
5. Vasoplegia After Cardiac Surgery Is Associated With Endothelial Glycocalyx Alterations.
Abou-Arab O; Kamel S; Beyls C; Huette P; Bar S; Lorne E; Galmiche A; Guinot PG
J Cardiothorac Vasc Anesth; 2020 Apr; 34(4):900-905. PubMed ID: 31570243
[TBL] [Abstract][Full Text] [Related]
6. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
Manghelli J; Brown L; Tadros HB; Munfakh NA
Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
[TBL] [Abstract][Full Text] [Related]
7. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
Shaefi S; Mittel A; Klick J; Evans A; Ivascu NS; Gutsche J; Augoustides JGT
J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1013-1022. PubMed ID: 29223724
[TBL] [Abstract][Full Text] [Related]
8. [Vasoplegic syndrome and its treatment with vasopressin during cardiac surgery with cardiopulmonary bypass].
Gilbert M; Lema G
Rev Med Chil; 2011 Mar; 139(3):368-72. PubMed ID: 21879171
[TBL] [Abstract][Full Text] [Related]
9. Incidence and predictors of vasoplegia after heart failure surgery.
van Vessem ME; Palmen M; Couperus LE; Mertens B; Berendsen RR; Tops LF; Verwey HF; de Jonge E; Klautz RJ; Schalij MJ; Beeres SL
Eur J Cardiothorac Surg; 2017 Mar; 51(3):532-538. PubMed ID: 28364440
[TBL] [Abstract][Full Text] [Related]
10. Vasoplegia during cardiac surgery: current concepts and management.
Fischer GW; Levin MA
Semin Thorac Cardiovasc Surg; 2010; 22(2):140-4. PubMed ID: 21092891
[TBL] [Abstract][Full Text] [Related]
11. Risk assessment and outcomes of vasoplegia after cardiac surgery.
Tsiouris A; Wilson L; Haddadin AS; Yun JJ; Mangi AA
Gen Thorac Cardiovasc Surg; 2017 Oct; 65(10):557-565. PubMed ID: 28612323
[TBL] [Abstract][Full Text] [Related]
12. Postoperative Vasoplegic Syndrome Is Associated With Impaired Endothelial Vasomotor Response in Cardiac Surgery: A Prospective, Observational Study.
Abou-Arab O; Martineau L; Bar S; Huette P; Amar AB; Caus T; Dupont H; Kamel S; Guinot PG; Lorne E
J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2218-2224. PubMed ID: 29548905
[TBL] [Abstract][Full Text] [Related]
13. Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival.
Mehaffey JH; Johnston LE; Hawkins RB; Charles EJ; Yarboro L; Kern JA; Ailawadi G; Kron IL; Ghanta RK
Ann Thorac Surg; 2017 Jul; 104(1):36-41. PubMed ID: 28551045
[TBL] [Abstract][Full Text] [Related]
14. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
Lenglet S; Mach F; Montecucco F
Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
[TBL] [Abstract][Full Text] [Related]
15. Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties.
Evora PR; Ribeiro PJ; Vicente WV; Reis CL; Rodrigues AJ; Menardi AC; Alves Junior L; Evora PM; Bassetto S
Rev Bras Cir Cardiovasc; 2009; 24(3):279-88. PubMed ID: 20011872
[TBL] [Abstract][Full Text] [Related]
16. Adverse Clinical Effects Associated With Non-catecholamine Pharmacologic Agents for Treatment of Vasoplegic Syndrome in Adult Cardiac Surgery.
Hwang KY; Phoon PHY; Hwang NC
J Cardiothorac Vasc Anesth; 2024 Mar; 38(3):802-819. PubMed ID: 38218651
[TBL] [Abstract][Full Text] [Related]
17. Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.
Busse LW; Barker N; Petersen C
Crit Care; 2020 Feb; 24(1):36. PubMed ID: 32019600
[TBL] [Abstract][Full Text] [Related]
18. Does cardiac surgery vasoplegia trigger the postpericardiotomy syndrome?
Edriss H; Lorenzana J; Nugent K
Am J Med Sci; 2015 May; 349(5):463-5. PubMed ID: 25647832
[No Abstract] [Full Text] [Related]
19. Vasoplegia After Surgical Left Ventricular Restoration: 2-Year Follow-Up.
van Vessem ME; Palmen M; Couperus LE; Stijnen T; Berendsen RR; Aarts LPHJ; de Jonge E; Klautz RJM; Schalij MJ; Beeres SLMA
Ann Thorac Surg; 2018 Nov; 106(5):1371-1378. PubMed ID: 30118711
[TBL] [Abstract][Full Text] [Related]
20. eComment: Port-access mitral valve repair in re-do surgery.
Gaeta R; Tancredi F; Monaco F; Lentini S
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):683. PubMed ID: 18664672
[No Abstract] [Full Text] [Related]
[Next] [New Search]
